Health Condition 1: N179- Acute kidney failure, unspecified Health Condition 2: N189- Chronic kidney disease, unspecified Health Condition 3: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
None listed
Sponsors
DrMaulin Shah
Eligibility
Inclusion criteria
Inclusion criteria: All covid positive (Rapid antigen test or RT PCR) patients admitted in shree Krishna hospital from March 2020 whose presenting creatinine is more than 1.4 mg/dl in Male or 1.2 mg/dl in Female or who are having oliguria /anuria (urine output less than 0.5 ml/kg/hour in first 24 hours -as per Standard KDIGO criteria) and who also received Remdesivir short or prolonged course during hospital stay will be included.
Exclusion criteria
Exclusion criteria: Those Covid positive patients with renal dysfunction will be excluded from study if they do not complete the course of remdesevir suggested by clinician. However, those patients who expired during treatment of remdesivir will be included in study and they will be analyzed separately.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Remdesevir is safe in patients with acute or chronic kidney injury and covid 19 infectionTimepoint: 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| reduction in hospital stay and mortality in chronic kidney disease patients infected with covid 19 infection and severe lung involvement treated with remdesevirTimepoint: 8 weeks | — |
Countries
India
Contacts
Public ContactDrMaulin Shah
Pramukhswami medical college,H M Patel centre for medical care and education
Outcome results
None listed